Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Case Report: Adjuvant radiation therapy for cardiac intimal sarcoma with long-term disease control.
Journal: Frontiers in oncology
Published: December 20, 2025
Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab).
Journal: Cancer research communications
Published: December 01, 2025
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2025
Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 02, 2025
The SCD1 inhibitor aramchol interacts with regorafenib to kill GI tumor cells in vitro and in vivo.
Journal: Oncotarget
Published: August 19, 2025
Durable disease control of adult-onset xanthogranuloma with time-limited MEK inhibition: a case report.
Journal: The British journal of dermatology
Published: August 06, 2025
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS).
Journal: JAMA oncology
Published: July 17, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 31, 2025
Letter Re: Ossifying fibromyxoid tumours: A case series subtitle: Successful control of a PHF1::TFE3-rearranged metastatic malignant ossifying fibromyxoid tumor using cabozantinib.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 09, 2025
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy.
Journal: Journal for immunotherapy of cancer
Published: February 12, 2025
Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials.
Journal: Current oncology (Toronto, Ont.)
Published: January 31, 2025
Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.
Journal: JCO precision oncology
Published: December 12, 2024
Last Updated: 09/26/2026